Moreover, SLC30A8 is a target for transcription factor 7-like 2 (TCF7L2) (49), variants of which have the highest impact on disease risk all of the T2D risk genes discovered so far by genome-wide association (14). This evidence concerns the gene TCF7L2 and type 2 diabetes mellitus.